Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data-Reference-Cited by-同舟云学术

Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data

Published:2021-07-28 Issue:4 Volume:107 Page:466-474
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Sandecká Viera¹^ORCID,Pour Luděk¹,Špička Ivan²,Minařík Jiří³^ORCID,Radocha Jakub⁴,Jelínek Tomáš⁵,Heindorfer Adriana⁶,Pavlíček Petr⁷,Sýkora Michal⁸,Jungová Alexandra⁹,Kessler Petr¹⁰,Wróbel Marek¹¹,Starostka David¹²,Ullrychová Jana¹³,Stejskal Lukáš¹⁴,Štork Martin¹^ORCID,Straub Jan²,Pika Tomáš³,Brožová Lucie¹⁵,Ševčíková Sabina¹⁶^ORCID,Maisnar Vladimír⁴,Hájek Roman⁵^ORCID

Affiliation:

1. Department of Internal Medicine, Hematology and Oncology University Hospital Brno Czech Republic

2. 1st Department of Medicine, Department of Hematology Charles University and General Hospital Prague Czech Republic

3. Department of Hemato‐Oncology University Hospital Olomouc Olomouc Czech Republic

4. 4th Department of Internal Medicine, Hematology University Hospital and Charles University in Hradec Kralove Hradec Kralove Czech Republic

5. Department of Hematooncology University Hospital OstravaUniversity of Ostrava Ostrava Czech Republic

6. Department of Clinical Hematology Hospital Liberec Czech Republic

7. Department of Internal Medicine and Hematology Charles University and Faculty Hospital Kralovske Vinohrady Prague Czech Republic

8. Department of Clinical Hematology Hospital Ceske Budejovice Ceske Budejovice Czech Republic

9. Hematology and Oncology Department Charles University Hospital Pilsen Pilsen Czech Republic

10. Department of Hematology and Transfusion Medicine Hospital Pelhrimov Czech Republic

11. Department of Clinical Hematology Hospital Novy Jicin Czech Republic

12. Department of Clinical Hematology Hospital Havirov Czech Republic

13. Department of Clinical Hematology Regional Health Corporation Masaryk Hospital Usti nad Labem Czech Republic

14. Department of Hematology Silesian Hospital in Opava Opava Czech Republic

15. Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic

16. Babak Myeloma Group Department of Pathophysiology Masaryk University Brno Czech Republic

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13683

Reference34 articles.

1. Epidemiology of Multiple Myeloma in the Czech Republic;Malúšková D;Klin Onkol,2017

2. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

3. How I manage frontline transplant ineligible multiple myeloma;Derudas D;Hematol Rep,2020

4. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

5. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell division cycle 37 change after bortezomib-based induction therapy helps to predict clinical response and prognosis in multiple myeloma patients;Hematology;2023-07-06